Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/12/1999US5965547 Inhibiting bone resorption, use for joint replacement, especially hip replacement in man
10/12/1999US5965546 1-[(2-pyrimidinyloxy)alkyl]4-(heteroaryl)piperazines and related compounds and their therapeutic utility
10/12/1999US5965544 Synthetic multivalent sLex containing polylactosamines and methods for use
10/12/1999US5965540 Antiinflammatory agent
10/12/1999US5965529 Inhibiting nitric oxide dependent contractility of the uterus
10/12/1999US5965522 Stem cell factor formulations and methods
10/12/1999US5965519 Covalent polar lipid conjugates with biologically-active compounds for use in salves
10/12/1999US5965493 Therapeutic Quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
10/12/1999US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999US5965411 Maltose-trehalose converting enzyme, and preparation and uses thereof
10/12/1999US5965407 Anthracycline compound 0624
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965392 A nucleic acid molecule; treating obesity or anorexia
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999US5965349 Methods of photodecontamination using synthetic media
10/12/1999US5965175 Feeding a dog a diet of pet food containing fermentable fibers having an organic matter disappearance of 15-60% when fermented by fecal bacteria for 24 hours, the fibers being present in amounts of 1-11%; increased elimination
10/12/1999US5965168 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
10/12/1999US5965167 Composition containing microspheres produced by imposing liquiflash on active agent and processing aid and coating of blend of polymers having different levels of hydrophilicity; sustained release
10/12/1999US5965166 Dry shearing a mixture of 60-95% acetaminophen and a direct compression vehicle, microcrystalline cellulose, into a stable homogenous granulate; mixing with a lubricant and compressing into a solid dose
10/12/1999US5965163 Solid dosage of drug in a matrix of a fusible material (m.p. 35-150 degrees c.) comprising a mixture of hydrophobic and hydrophilic carriers formed by controlled granulation, comminution and mechanically working the agglomerants
10/12/1999US5965161 Extruded multi-particulates
10/12/1999US5965158 Liposomal-polyene preliposomal powder and method for its preparation
10/12/1999US5965157 Method to provide for production of hair coloring pigments in hair follicles
10/12/1999US5965156 Amphotericin B liposome preparation
10/12/1999US5965155 Transdermal therapeutic system with pentylene tetrazol as active substance
10/12/1999US5965152 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/12/1999US5965127 Exocellular polysaccharide produced by streptococcus thermophilus
10/12/1999US5965126 use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/12/1999US5965121 Compounds and compositions for delivering active agents
10/12/1999US5965119 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/12/1999US5965118 Polymer-platinum compounds
10/12/1999US5964224 Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor
10/12/1999CA2175572C Antiperspirants and method of applying antiperspirant using a shaped article
10/12/1999CA2168732C Gelatin capsules containing a highly concentrated acetaminophen solution
10/12/1999CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses
10/12/1999CA2024476C Benzopyranone-.beta.-d-thioxylosides their method of preparation and their use in therapy
10/12/1999CA2012219C D-desosamine retinoic esthers, process for their preparation and use in human or veterinary and in cosmetology
10/12/1999CA1340785C Platelet activating factor antagonists
10/12/1999CA1340784C 7-(2-methyl-4-aminopyrrolidinyl)naphthyridine and quinoline compounds
10/12/1999CA1340782C Naphthyridone antibacterial compounds
10/10/1999CA2273546A1 Nefazodone dosage form
10/10/1999CA2268567A1 Use of conjugated linoleic acid
10/10/1999CA2266796A1 Use of at least one hydroxystilbene in a skin-toning composition
10/10/1999CA2263059A1 New peptide compounds analogue to glucagon-like-peptide-1 (7-37), their preparation process and the pharmaceutical compositions containing them
10/08/1999CA2267844A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/08/1999CA2234349A1 Method of reducing boar taint
10/07/1999WO1999050657A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999WO1999050456A1 P53-regulated genes
10/07/1999WO1999050418A1 Treatment and diagnosis of staphylococcal infections
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050276A1 3',3'-n-bis-substituted macrolide lhrh antagonists
10/07/1999WO1999050275A2 Macrolide lhrh antagonists
10/07/1999WO1999050272A1 Phosphinic acid derivatives
10/07/1999WO1999050271A1 Novel process for the fermentative production of cephalosporin
10/07/1999WO1999050269A2 Porphyrins and their use as photosensitizer
10/07/1999WO1999050268A2 Substituted indolealkanoic acids
10/07/1999WO1999050267A1 Process for producing isooxazolidinedione compound
10/07/1999WO1999050266A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
10/07/1999WO1999050265A1 Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents
10/07/1999WO1999050263A1 Quinolones as serine protease inhibitors
10/07/1999WO1999050262A1 Pde iv inhibiting pyridine derivatives
10/07/1999WO1999050258A1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof
10/07/1999WO1999050257A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
10/07/1999WO1999050256A1 Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections
10/07/1999WO1999050255A2 Disubstituted pyrazolines and triazolines as factor xa inhibitors
10/07/1999WO1999050254A1 Quinoxalinones as serine protease inhibitors such as factor xa and thrombin
10/07/1999WO1999050253A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/07/1999WO1999050252A2 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999WO1999050251A2 Cyclin dependent kinase inhibitors
10/07/1999WO1999050250A1 Hiv inhibiting pyrimidine derivatives
10/07/1999WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999WO1999050248A1 Pyridazinone hydrochloride compound and method for producing the same
10/07/1999WO1999050247A1 Compounds with activity on muscarinic receptors
10/07/1999WO1999050245A1 Indole derivatives with antiviral activity
10/07/1999WO1999050242A1 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists
10/07/1999WO1999050241A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
10/07/1999WO1999050239A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
10/07/1999WO1999050237A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
10/07/1999WO1999050230A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999WO1999049901A1 Water soluble paclitaxel derivatives
10/07/1999WO1999049897A1 Hemoglobin-polysaccharide conjugates
10/07/1999WO1999049896A1 A drug composition containing sodium pravastatin
10/07/1999WO1999049895A2 Method for increasing the permeability of horny human tissue
10/07/1999WO1999049888A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049874A1 Dextran formulations and method for treatment of inflammatory joint disorders
10/07/1999WO1999049873A1 Nucleosides with antiviral and anticancer activity
10/07/1999WO1999049872A1 Preventives for alcoholic gastritis
10/07/1999WO1999049871A1 Method of inhibiting membrane-type matrix metalloproteinase
10/07/1999WO1999049870A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
10/07/1999WO1999049869A1 Methods to potentiate intravenous estramustine phosphate
10/07/1999WO1999049868A1 Sustained-release composition containing cefaclor
10/07/1999WO1999049867A1 Novel galenic formulations of meloxicam for oral administration
10/07/1999WO1999049865A1 Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation
10/07/1999WO1999049864A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999WO1999049863A1 Sustained release preparations
1 ... 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 6451 6452 ... 7860